Vimarsana
Biggest News Aggregation in the World

Emmanuel Pothos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Emmanuel Pothos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Emmanuel Pothos Today - Breaking & Trending Today

Copernicus Therapeutics: Newly Presented Preclinical Data Shows Potential for Novel Gene Therapy To Treat Opioid Use Disorder - Second Year of NID/ANIH Grant Support Will Enable Further Exploration of Hypothesis - Vimarsana News

Copernicus Therapeutics: Newly Presented Preclinical Data Shows Potential for Novel Gene Therapy To Treat Opioid Use Disorder - Second Year of NID/ANIH Grant Support Will Enable Further Exploration of Hypothesis

Dr. Barbara Waszczak, Professor of Pharmacology at Northeastern University's Bouvé College of Health Sciences, and collaborators from Cummings School of Veterinary Medicine at Tufts University and Tufts

Could a Nasal Spray Stop Opioid Cravings and Reduce Relapse? - Vimarsana News

Could a Nasal Spray Stop Opioid Cravings and Reduce Relapse?

An intranasal opioid treatment method could restore dopamine transmitters in the brain and "reset the reward system so it’s normal again."

Northeastern University and Copernicus Therapeutics, Inc. Awarded $14.7 Million NIDA/NIH Grant to Develop a Gene Therapy Approach for Treating Opioid Use Disorder - Vimarsana News

Northeastern University and Copernicus Therapeutics, Inc. Awarded $14.7 Million NIDA/NIH Grant to Develop a Gene Therapy Approach for Treating Opioid Use Disorder

Dr. Barbara Waszczak, Professor of Pharmacology at Northeastern University's Bouvé College of Health Sciences, is the Principal Investigator and Project...

Copernicus Therapeutics, Northeastern University to develop gene therapy for treating opioid use disorder - Vimarsana News

Copernicus Therapeutics, Northeastern University to develop gene therapy for treating opioid use disorder

An initial $6.7 million grant comes from the National Institute on Drug Abuse, part of the National Institutes of Health. Copernicus, a clinical-stage gene therapy company in Cleveland, and Northeastern, which is in Boston, said the grant has the potential for an additional $8 million in Phase 2 funding 'to further move the gene therapy toward clinical trials.'

We know the cost of free choice and locality - in physics and not only - Vimarsana News

We know the cost of free choice and locality - in physics and not only

 E-Mail IMAGE: Artistic imagery about the famous Bell experiments, with ballet dancers personifying experimental arrangements in space-time separated labs. The strings of ones and zeros allude to the violation of free choice... view more  Credit: Source: IFJ PAN / Iwona Michniewska Do we have free choice or are our decisions predetermined? Is physical reality local, or does what we do here and now have an immediate influence on events elsewhere? The answers to these questions are sought by physicists in the Bell inequalities. It turns out that free choice and local realism can be sk...